معرفی
Dr. Sebastian Kurz is an Associate Professor at Yale School of Medicine, specializing in pulmonary and critical care medicine. He directs the COPD clinic and is part of the Advanced Airways Disease Program. His clinical expertise includes complex structural lung diseases, inflammatory airways conditions, and mycobacterial infections such as tuberculosis, NTM, and bronchiectasis. He holds an MD and PhD in Microbiology from Julius-Maximilians University Würzburg, Germany, and completed residency and fellowship training at Case Western Reserve University in Cleveland.
Research Focus: Dr. Kurz focuses on developing novel antibiotic combinations to treat drug-resistant mycobacteria, particularly targeting cell wall synthesis mechanisms. His work emphasizes β-lactam antibiotics and β-lactamase inhibitors like durlobactam. Key areas include Mycobacterium abscessus and drug-resistant tuberculosis.
Professional Affiliations: Board certified in Pulmonary and Critical Care Medicine, he is a Fellow of the American College of Chest Physicians (FCCP) and active in the American Thoracic Society and European Respiratory Society.
Recent Contributions: His 2025 studies explored dual β-lactam therapies for Mycobacterium abscessus, while 2024 work highlighted durlobactam’s role in combating mycobacterial infections. He has published extensively on antibiotic synergy and novel treatment strategies.
